23andMe to Report FY2024 Third Quarter Financial Results

SOUTH SAN FRANCISCO, Calif., Jan. 24, 2024 -- 23andMe Holding Co. , a leading human genetics and biopharmaceutical company with a mission to help people access, understand, and benefit from the...

Related Keywords

Cian Cooney ,Securities Exchange ,Me Holding Co ,Exchange Commission ,Nasdaq ,Say Technologies ,Securities Act ,Securities Exchange Act ,Annual Report ,Quarterly Reports ,Current Reports ,Relations Contact ,Markets ,